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1 o INTRODUCTION 
The basement membrane glycoprotein laminin af- 
fects cell attachment, polarisation, migration and dif- 
ferentiation [l]. The most commonly studied isoform, 
murine EHS laminin, has an A (440 kDa), a Bl 
(220 kDa) and a B2 (220 kDa) subunit (21, although 
laminin isoforms with alternative subunits have also 
been described (3-51. Different cell types can use a 
variety of receptors, including integrins, to interact with 
different sites on the EMS laminin molecule [l&9], 
although, since multiple iaminin isoforms exist, the 
physiological relevance of such interactions is: not clear. 
To date the only cell-binding studies with laminin from 
another source have utilised human placental aminin 
prepared using pepsin digestion [IO-la], but with EMS 
laminin such treatment reveals a cryptic binding site not 
present in the intact molecule [ 131 and destroys the 
long-arm binding site [14]. Here we directly compare 
cell attachment to murine ENS Iaminin and human 
placental laminin purified without the use of proteases. 
Our results suggest that for a given cell type, different 
receptors mediate binding to laminin molecules of dif- 
ferent origins. 
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2, MATERIALS AND METHODS 
Human placental laminin was purified ns previously described [IS], 
but with an extra purification step on gelatin3epharosc co remove 
fibroncctin. Murine EHS laminin was purified as described (161. A 
manoclonal antibody against the cell binding region of human 
fibronrctin (‘Iuios, US) showed no reactivity by ELISA with either 
laminin preparation (not shown). 
Cell attachment assays were carried out as described [14], except 
numbers of adherent cells were assayed while still on the plates by 
measuring hexosanrinidasc acr,ivity [17]. Human laminin concentra- 
tions were estimated from their absorbance at 280 nm normalised to 
an EHS laminin standard. Cell attachment is expressed as % of cells 
added to the wells, with error bars showing the standard deviation 
(n = 3-4). For inhibition experiments with anti-laminin antisera, 
coated and blocked plates were incubated with the indicated dilutions 
of antiserum for I h at 37OC, after which the plates were washed with 
phosphate-buffered saline and the cells added. For inhibition ex- 
periments with anti-integrin monoclonal antibodies, cells were in- 
cubated with either GOH3 (rat anti-mouse a6 [15], gift of A. Son- 
nenberg, Amsterdam, The Netherlands), PISS (mouse anti-humana 
[ 191, Telios, US) or PlE6 (mouse anti-human a2 [ 191, Telios, US) for 
1 h at 37OC, before being added to the plates. Meat treatment of 
laminin was carried out as described [I4]. 
3. RESULTS AND DISCUSSION 
The abilities of human placental laminin and murine 
EMS laminin to promote attachment of RuGli (rat 
glioblastoma), HT1080 (human fibrosarcoma) and I316 
(mouse melanoma) cell lines were compared (Fig. l), 
All three cell lines attached to both types of laminin and 
slightly lower amounts of human placental Iaminin than 
EHS laminin were required to support he same level of 
binding. Maximum levels of cell binding for RuGli 
(70~80%) and for MT1080 (40-5OOIo) cells were similar 
on both types o’f laminin, and for I316 cells were slightly 
higher in the human laminin (60%) than on EHS 
laminin (45%). 
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Previous studies have shown that the long-arm region 
(E8) of EHS laminin contains a major cell-artachmcnc 
site and is involved in many of Iaminin’s biological 
functions [14,20-231. This region of EHS laminin is 
heat.scns&ivc, with cell attachment activity being lost 
after heating to 60-70°C [14]. Humrtn placental laminin 
was more resistant to heat-treatment, with cemperaturcs 
of go-90°C being required to abolish HTIOSO cell ar- 
tachment (Fig. 2), indicating either that the major cell 
binding region of human placental aminin is not its 
long-arm region or that its long-arm region is thermally 
more stable and therefore structurally different from 
that of EMS laminin. Further evidence that the major 
cell binding regions of the two types of laminin are 
distinct was provided by the finding that a rabbit an- 
tiserum against EHS laminin could btock binding of 
Rugli cells to EHS laminin but not to human placental 
laminin (Fig. 3) although this antiserum cross-reacted 
with the human laminin by ELISA at these concentra- 
tions (not shown). 
Many cell lines have been shown to USC an ab-subunit 
containing intcgrin to bind to EHS lanrinin via the 58 
region [g-8]. We thcrcforc tested the ability of the 
monoclonal antibody GOH3 [ 181, which can block 
rY6-intcgrin-mediated cell attachment to EHS laminin 
[a-9], to block B16 and HI’1080 cell binding to human 
placental laminin. GOH3 completely inhibited binding 
of both cell lines to EHS laminin but had no significant 
effect on the binding of the same cells to human placcn- 
tal laminin (Fig. 4). Therefore, the cells are using dif- 
ferent receptors to bind to these two types of laminin. 
At present it is unclear whether the differences in the 
cell binding sites of the two laminin molecules are due 
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Fig. 2. HT1080 cell binding to heat treated EHS laminin (0; 50 
&ml) and human placental aminin (v : IO &ml). 
Fig. 3. Wells coated wit.h murine EWS laminin (O&B; 5 &ml) or 
human placental laminin (V V; 2 pg/ml) were incubated with rabbit 
anti-EHS laminin antiserum (closed symbols) or normal rabbit serum 
(open symbols). After removing excess antiserum, RuGli cells were 
allowed to attach. 
6 
to species or tissue heterogeneity, or to peculiarities of 
tumour-derived laminin. Tissue-specific laminin 
isoforms have been described [3-S] and the human 
laminin used in this study contains a subunit which is 
antigenically unrelated to the EHS laminin subunits 
(unpublished observations). 
Since HT1080 cells express high levels of the intcgrin 
subunits ru2 and cu3 (unpublished results), both of which 
have been reported to act in combination with pl as 
laminin receptors [lo- 12,241, we also studied the affect 
of monoclonal antibodies against these subunits on 
HT1080 ceil binding to human placental laminin. PlE6 
(anti-a2 [19]) blocked HT1080 cell binding to human 
collagens I and If (Fig. 5A) but had no effect on their 
binding to either murine EMS or human placenta1 
laminin (Fig. SB). This suggests that the HTlO80 cells 
are not using an cu2-integrin as a major human placenta1 
larninin receptor and eliminates the possibility that col- 
lagen contamination of the human laminin preparation 
is responsible for its cell adhesion-promoting activity. 
Previously observed ly2-mediated cell attachment o 
laminin appears to be cell-type specific [12,24]. We 
observed no significant inhibition of MT1080 cell at- 
tachment with PlB5 (anti-a3) on any of the ligands 
tested (human and murine laminin, collagens I and II 
(Fig. SC,@ and fibronectin (not shown)) in contrast o 
previous reports [191. Thus, we were unable to draw any 
conclusions about the role of a3-integrins, which have 
been shown to bind to pepsin-digested human placental 
laminin [lo, 111, in mediating HT1080 cell attachment 
to intact human placental laminin. In addition, we can- 
not rule out the possibility that HT1080 cells are using 
an a6-integrin as a minor human placental aminin 
receptor in combination with another eceptor. Further 
experiments o identify the HT1080 receptor for human 
placental laminin arc currently being carried out. 
This report indicates for the first time that cells may 
use a distinct receptor repertoire to bind to laminin 
motccules of different origins, The interaction of a6 in* 
tegrins with laminin has been demonstrated for several 
cell types [G-9] and has been shown to be functionally 
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Fig, 5. HT1080 cells were incubated with PlE6 (ank2) ascites C&B) 
or PlB5 (anti-o3) ascites (C,D) then added to wells coated with 3 
&ml murine EMS laminin (O), human placental iaminin (V). 
human collagen 1 (m) or human collaRen II (0). 
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